Skip to main content
Log in

In HIV-Infected Immunological Non-Responders, Hepatitis C Virus Eradication Contributes to Incomplete Normalization of Systemic Inflammation Indexes, but Does Not Lead to Rapid CD4+ T-Cell Count Recovery

  • BIOCHEMISTRY, BIOPHYSICS, AND MOLECULAR BIOLOGY
  • Published:
Doklady Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

In HIV-positive individuals taking antiretroviral therapy, coinfection with hepatitis C virus (HCV) increases systemic inflammation, which interferes with the CD4+ T-cells regeneration. This study evaluated the effect of HCV eradication on systemic inflammation and CD4+ T-cell regeneration in patients who gave poor response to antiretroviral therapy, the so-called “immunological non-responders” (INRs). HIV-infected patients who received a course of direct-acting antivirals for treating hepatitis C were examined. The control groups included HIV/HCV-coinfected INRs and relatively healthy volunteers. It was established for the first time that HCV eradication is not accompanied by a complete suppression of systemic inflammation, but improves the T-cell pool composition: in INRs, the blood CD4+/CD8+ T-lymphocyte ratio increases and approaches those of healthy individuals. Apparently, in INRs treated for hepatitis C, the immune system recovery takes time and may be incomplete.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

REFERENCES

  1. Chew, K.W. and Bhattacharya, D., Virologic and immunologic aspects of HIV–hepatitis C virus coinfection, AIDS, 2016, vol. 30, no. 16, pp. 2395–2404.

    Article  CAS  PubMed  Google Scholar 

  2. van Santen, D.K., van der Helm, J.J., Touloumi, G., et al., Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort, AIDS, 2019, vol. 33, no. 2, pp. 327–337.

    Article  CAS  PubMed  Google Scholar 

  3. Rb-Silva, R., Goios, A., Kelly, C., et al., Definition of immunological nonresponse to antiretroviral therapy: a systematic review, J. Acquired Immune Defic. Syndr., 2019, vol. 82, no. 5, pp. 452–461.

    Article  Google Scholar 

  4. Yang, X., Su, B., Zhang, X., et al., Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: challenges of immunological non-responders, J. Leukoc. Biol., 2020, vol. 107, no. 4, pp. 597–612.

    Article  CAS  PubMed  Google Scholar 

  5. Robinson, M.W., Harmon, C., and O’Farrelly, C., Liver immunology and its role in inflammation and homeostasis, Cell Mol. Immunol., 2016, vol. 13, no. 3, pp. 267–276.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Saidakova, E.V., Shmagel, K.V., Korolevskaya, L.B., et al., (CD8+) T cell expansion in HIV/HCV coinfection is associated with systemic inflammation, Dokl. Biol. Sci., 2017, vol. 474, no. 1, pp. 126–128.

    Article  CAS  PubMed  Google Scholar 

  7. Marcello, T., Grakoui, A., Barba-Spaeth, G., et al., Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics, Gastroenterology, 2006, vol. 131, no. 6, pp. 1887–1898.

    Article  PubMed  Google Scholar 

  8. Pagliaccetti, N.E., Eduardo, R., Kleinstein, S.H., et al., Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication, J. Biol. Chem., 2008, vol. 283, no. 44, pp. 30079–30089.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Witte, K., Gruetz, G., Volk, H.D., et al., Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines, Genes Immun., 2009, vol. 10, no. 8, pp. 702–714.

    Article  CAS  PubMed  Google Scholar 

  10. Li, Q., Kawamura, K., Ma, G., et al., Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents, Eur. J. Cancer, 2010, vol. 46, no. 1, pp. 180–190.

    Article  CAS  PubMed  Google Scholar 

  11. Sato, A., Ohtsuki, M., Hata, M., et al., Antitumor activity of IFN-lambda in murine tumor models, J. Immunol., 2006, vol. 176, no. 12, pp. 7686–7694.

    Article  CAS  PubMed  Google Scholar 

  12. Zitzmann, K., Brand, S., Baehs, S., et al., Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells, Biochem. Biophys. Res. Commun., 2006, vol. 344, no. 4, pp. 1334–1341.

    Article  CAS  PubMed  Google Scholar 

  13. Zuccala, P., Latronico, T., Marocco, R., et al., Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV/HCV coinfected subjects, Int. J. Mol. Sci., 2022, vol. 23, no. 19, pp. 1193–1213.

    Article  Google Scholar 

  14. Hengst, J., Falk, C.S., Schlaphoff, V., et al., Direct-acting antiviral-induced hepatitis C virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis C, J. Infect. Dis., 2016, vol. 214, no. 12, pp. 1965–1974.

    Article  CAS  PubMed  Google Scholar 

  15. Lund, L.T., Brockner, S.C., Kazankov, K., et al., Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology, Scand. J. Gastroenterol., 2018, vol. 53, no. 8, pp. 986–993.

    Article  Google Scholar 

  16. Serti, E., Chepa-Lotrea, X., Kim, Y.J., et al., Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function, Gastroenterology, 2015, vol. 149, no. 1, pp. 190–200.

    Article  CAS  PubMed  Google Scholar 

  17. Meissner, E.G., Wu, D., Osinusi, A., et al., Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome, J. Clin. Invest., 2014, vol. 124, no. 8, pp. 3352–3363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Meissner, E.G., Kohli, A., Higgins, J., et al., Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infection, Hepatol. Commun., 2017, vol. 1, no. 7, pp. 586–594.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Marino, A., Zafarana, G., Ceccarelli, M., et al., Immunological and clinical impact of DAA-mediated HCV eradication in a cohort of HIV/HCV coinfected patients: monocentric italian experience, Diagnostics (Basel), 2021, vol. 11, no. 12, pp. 2336–2250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bandera, A., Lorenzini, P., Taramasso, L., et al., The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort, J. Viral Hepat., 2021, vol. 28, no. 5, pp. 779–786.

    Article  CAS  PubMed  Google Scholar 

Download references

ACKNOWLEDGMENTS

In this study, we used the equipment of the Core Facility “Investigations of Materials and Substances,” Perm Federal Research Center, Ural Branch, Russian Academy of Sciences.

Funding

The study was carried out under the state assignment (no. 121112500044-9) and was supported by the Russian Foundation for Basic Research and the Perm krai within the framework of the scientific project no. 20-415-596002.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Saidakova.

Ethics declarations

Conflict of interest. The authors declare that they have no conflicts of interest.

Statement of compliance with standards of research involving humans as subjects. The work plan was approved by the Ethics Committee of the Perm Regional Center for Combating AIDS and Infectious Diseases (committee registration no. IRB00008964), protocol No. 31 dated March 3, 2017. Informed consent was obtained from each participant.

Additional information

Translated by M. Batrukova

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saidakova, E.V., Korolevskaya, L.B., Shmagel, N.G. et al. In HIV-Infected Immunological Non-Responders, Hepatitis C Virus Eradication Contributes to Incomplete Normalization of Systemic Inflammation Indexes, but Does Not Lead to Rapid CD4+ T-Cell Count Recovery. Dokl Biochem Biophys 512, 274–278 (2023). https://doi.org/10.1134/S1607672923700448

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1607672923700448

Keywords:

Navigation